ep hiv-1090
Vaccineexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2002 (NCT00052182)
Timeline
2000s
- Jan 1, 2002
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ep hiv-1090
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00141024 | Phase 1 | Jan 1, 2006 | Asociación Civil Impacta Salud y Educación, Peru, National Institute of Allergy and Infectious Diseases (NIAID), University of Rochester |
| NCT00054860 | Phase 1 | Feb 11, 2003 | National Institute of Allergy and Infectious Diseases (NIAID), St. Louis University |
| NCT00052182 | Phase 1 | Oct 1, 2002 | National Institute of Allergy and Infectious Diseases (NIAID), University of California, San Diego |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 3 | 1 | 2002 |
| Asociación Civil Impacta Salud y Educación, Peru | Academic/Hospital | 1 | 0 | 1 | 2006 |
| St. Louis University | Academic/Hospital | 1 | 0 | 1 | 2003 |
| University of California, San Diego | Academic/Hospital | 1 | 0 | 1 | 2002 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2006 |
5 organizations
Page 1 / 1